Recently, when diabetes-mediated IL-17A production was ablated by therapeutically inhibiting RORγt, retinal capillary degeneration was ameliorated and the onset of non-proliferative diabetic retinopathy was halted [15]. Here, IL17A is linked to diabetes mellitus.